FROM Jon Henke
Sotomayor Hearings; Healthcare; Goldman Sachs Is Sotomayor a shoe-in? The battle for healthcare reform turns critical. Plus, Goldman Sachs and JP Morgan earn millions. Is that good for the country? (With Arianna Huffington and Tony Blankley away, we welcome two new guest hosts, John Henke and Mike Murphy.)
Republicans Regroup as the Opposition Republicans are pointing fingers at one another, but most agree on one thing: even if John McCain had not lost to Barack Obama , the GOP was in trouble. They were saddled with George Bush and the war in Iraq. They failed to control healthcare costs or monitor the economy. Now the party of Ronald Reagan has no consensus on leadership or a set or principles to hold its factions together. We ask a cross-section of Republican operatives and philosophers, what should happen next?
GOP 'Nukes' the Senate filibuster on SCOTUS nominees Senate Democrats today blocked Judge Neil Gorsuch's appointment to the US Supreme Court… but just for the moment. The Republican majority has changed the rules to force a likely confirmation as soon as tomorrow.
Trump's ethical conflicts pile up as transparency diminishes President Trump's refusal to reveal his income tax returns is just one example of a lack of transparency that could be hiding conflicts of interest. Other conflicts are already obvious from his appointments. And he's being sued for using his job to increase his profits.
Is Venezuela becoming a dictatorship? Venezuela may have the world's largest oil reserves, but it's a nation in trouble… economically and politically. Is a populist promise to rescue democracy turning out to be a prelude to dictatorship?
Mixed Messages from US diplomats on the new hard line on Syria Since President Trump's surprise retaliation against Syria's use of chemical weapons, Bashar al-Assad has used the same airport to launch conventional attacks on his own people. It's not clear what the US, its allies — or Vladimir Putin's Russia -- plan to do now.